Eurocine Vaccines AB (publ) reported earnings results for the third quarter and nine months ended March 31, 2024. For the third quarter, the company reported revenue was SEK 0.027 million compared to SEK 0.002 million a year ago. Net loss was SEK 2.08 million compared to SEK 3.21 million a year ago.
For the nine months, revenue was SEK 0.029 million compared to SEK 0.005 million a year ago. Net loss was SEK 10.84 million compared to SEK 15.26 million a year ago.